Clinical Outcomes of DEB-TACE in Hepatic Metastatic Neuroendocrine Tumors: A 5-Year Single-Institutional Experience.

Mina S Makary, Luis E Regalado, Jonathan Alexander,Vineeth Sukrithan,Bhavana Konda,Jordan M Cloyd

Academic radiology（2023）

引用 0|浏览1

暂无评分

摘要

Based on this institutional experience, DEB-TACE is an acceptable locoregional therapy choice for hepatic metastases of NET due to its tolerable safety profile and relative efficacy.

查看译文

关键词

Efficacy,Liver metastases,Neuroendocrine tumors,Safety,Transarterial chemoembolization

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要